by John Finey | Sep 1, 2022 | Blog, Brexit
Do you supply to customers in Northern Ireland – If you do, then you will be aware of a range of issues following Brexit and that we are still some way away from a long term agreement. However, we wanted to highlight a specific issue.
by Amelia Holmes | Feb 9, 2022 | Blog, Brexit, MHRA
Advanced Therapy Medicinal Products (ATMPs) are medicines based on genes, tissues or cells for human use. ATMPs offer an innovative perspective for the treatment of disease and injury.
by Sally Finlayson | Jul 21, 2021 | Blog, Brexit, GDP/RP, MHRA, RP, Training, WDA(H)
Following Brexit and GB leaving the EU the MHRA have advised that GB wholesale dealers now need to appoint an RPi
by Sally Finlayson | Jun 7, 2021 | Blog, Brexit, Training
Are you importing medicines? Find out about the role of the RPi – Responsible Person (imports) – in our intro to the role training session….
by Sally Finlayson | Jun 2, 2021 | Blog, Brexit
A UK-Canada Trade Continuity Agreement entered into force 01/04/21. The two countries will continue to recognise each others GMP Certificates
by Sally Finlayson | Jun 1, 2021 | Blog, Brexit, Falsified Medicines, FMD, GDP/RP, Good Distribution Practice - GDP
The EMVO has published a Letter of Announcement on using the correct status when decommissioning pharmaceutical products…